◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Kissei Pharmaceutical Co., Ltd. (4547) Financial History

Name: Kissei Pharmaceutical Co., Ltd. (4547) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Drug Manufacturers - Specialty & Generic · DATA UPDATED 2026-08-11

Kissei Pharmaceutical Co., Ltd. (4547) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Matsumoto, Japan with about 1,786 employees. Its market capitalization is roughly JPY 171 billion. In the fiscal year ended 2026-03-31, 4547 reported JPY 97.4B in revenue and JPY 13.8B in net income.

Kissei Pharmaceutical Co., Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan and internationally.

Interactive charts & full statements →

4547 Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	JPY 97.4B	JPY 88.3B	JPY 75.6B	JPY 67.5B
Gross Profit	JPY 45.8B	JPY 44.1B	JPY 37.3B	JPY 32.4B
Operating Income (EBIT)	(JPY 2.9B)	JPY 5.8B	JPY 4.0B	(JPY 1.1B)
Net Income	JPY 13.8B	JPY 12.0B	JPY 11.2B	JPY 10.5B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4547 Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(JPY 4.8B)	(JPY 3.8B)	(JPY 3.7B)	(JPY 3.1B)	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

4547 Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	JPY 275.1B	JPY 244.1B	JPY 260.9B	JPY 221.2B
Total Liabilities	JPY 43.6B	JPY 33.9B	JPY 39.8B	JPY 26.4B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 4547 viewer.

4547 Metric Deep Dives

Other Companies in Drug Manufacturers - Specialty & Generic

4516 · Nippon Shinyaku Co., Ltd. — $242 billion
3692 · Hansoh Pharmaceutical Group Company Limited — $200 billion
4887 · Sawai Group Holdings Co., Ltd. — $184 billion
4553 · Towa Pharmaceutical Co., Ltd. — $182 billion
4521 · Kaken Pharmaceutical Co., Ltd. — $151 billion
TEVA · Teva Pharmaceutical Industries Limited — ₪125 billion
4534 · Mochida Pharmaceutical Co., Ltd. — $114 billion
4559 · Zeria Pharmaceutical Co., Ltd. — $91 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← 4544 All “0-9” companies 4548 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.